Research and Development

Showing 15 posts of 8964 posts found.


Astellas Pharma and BMT CTN announce phase 3 data for gilteritinib

June 9, 2023 Research and Development Astellas Pharma, BMT CTN, Haematology, gilteritinib, leukaemia, pharmaceutical

Japanese pharmaceutical company Astellas Pharma and the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) have presented their phase …

Innate Pharma announces drug researched with Sanofi receives FDA Fast Track Designation

June 8, 2023 Research and Development Cancer, FDA, Haematology, Innate Pharma, Sanofi, haematology

Innate Pharma has announced that the drug jointly researched between itself and Sanofi has received US Food and Drug Administration (FDA) …

Axol Bioscience and StrataStem collaborate to deliver ‘clinical trial in a dish’ for Alzheimer’s disease

June 7, 2023 Research and Development Alzheimer's, Axol Bioscience, Neurology, StrataStem

Pluripotent stem cell technology provider Axol Bioscience has signed an exclusive agreement with UK-based StrataStem to access and commercialise its …

UK plans £40m drug trial for Novo Nordisk’s Wegovy to aid NHS in treating obesity

June 7, 2023 Research and Development NHS, Novo Nordisk, Obesity, Wegovy, clinical trial, obesity

The UK Government has announced plans to launch a pilot programme which will provide GPs with Novo Nordisk’s Wegovy (semaglutide), …

GRAIL and University of Oxford showcase first prospective study results for multi-cancer early detection test

June 6, 2023 Research and Development Cancer, GRAIL, Oncology, University of Oxford, cancer testing

US-based healthcare company GRAIL and the University of Oxford, UK, have announced encouraging first prospective study results at the American …

ISA Pharmaceuticals highlights positive clinical data at ASCO

June 6, 2023 Research and Development ASCO, Cancer, HPV, ISA Pharmaceuticals, Oncology

Clinical stage biotechnology company ISA Pharmaceuticals has announced positive phase 1 data at the American Society of Clinical Oncology (ASCO) …

GSK receives FDA file acceptance for Jemperli plus chemotherapy for treating endometrial cancer

June 6, 2023 Research and Development GSK, Jemperli, Oncology, endometrial cancer, oncology

GSK has announced that the US Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for …

AstraZeneca’s phase 4 trial stopped early after reaching pre-specified criteria

June 5, 2023 Research and Development ANNEXA-I, Andexxa, AstraZeneca, Neurology, clinical trial

AstraZeneca has announced that its post-marketing phase 4 ANNEXA-I trial has been stopped early after reaching its pre-specified stopping criteria. …

Allogene Therapeutics shares updated ALLO-501/501A phase 1 data in large B-cell lymphoma at ASCO annual meeting

June 5, 2023 Research and Development Allogene, LBCL, Oncology, lymphoma, oncology

Allogene Therapeutics has shared updated data from the phase 1 ALPHA/ALPHA2 trials of ALLO-501/501A in patients with relapsed/refractory (r/r) large …

BioInvent receives Investigational New Drug approval for monoclonal antibody BI-1910

June 2, 2023 Research and Development BioInvent, NSCLC, Oncology, monoclonal antibody

Swedish clinical stage biotech company BioInvent has announced that it has received Investigational New Drug (IND) approval for its monoclonal …

FDA approves Pfizer’s RSV vaccine for older adults

June 1, 2023 Research and Development FDA, Infections and infestations, Pfizer, RSV, Vaccine

Global pharmaceutical company Pfizer has announced that the US Food and Drug Administration (FDA) has approved its respiratory syncytial virus …

Sanofi announce positive phase 2 data for MS drug frexalimab

June 1, 2023 Research and Development Neurology, Sanofi, clinical trial, frexalimab, multiple sclerosis

French pharmaceutical and healthcare company Sanofi have announced positive trial data from its phase 2 clinical study into its relapsing …

SNIPR Biome reports positive findings for first-in-human, CRISPR-based microbial gene therapy

May 31, 2023 Research and Development Infections and infestations, SNIPR Biome, clinical trial, crispr, gene therapy

Danish CRISPR-based microbial gene therapy company SNIPR Biome have announced positive interim data from its phase 1 clinical trial with …

Scientists use AI to find new antibiotic to fight superbug

May 26, 2023 Research and Development AI, Microbiology, WHO, abaucin, antibiotic resistance

Scientists at McMaster University and the Massachusetts Institute of Technology (MIT) have utilised artificial intelligence (AI) in order to discover …

BioInvent and Transgene announce positive phase 1a solid tumour trial data

May 25, 2023 Research and Development BioInvent, Oncology, Transgene, clinical trials, oncology, tumours

Sweden-based BioInvent and French Transgene, both biotech companies, have reported positive phase 1a data from a trial studying BT-001 for …

Latest content